Strategies to enhance linkages between care for HIV/AIDS in jail and community settings.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 21347900)

Published in AIDS Care on March 01, 2011

Authors

Jeffrey Draine1, Divya Ahuja, Frederick L Altice, Kimberly Jacob Arriola, Ann K Avery, Curt G Beckwith, Cristina A Booker, Ann Ferguson, Hayley Figueroa, Thomas Lincoln, Lawrence J Ouellet, Jeffrey Porterfield, Anne C Spaulding, Melinda J Tinsley

Author Affiliations

1: School of Social Policy and Practice, University of Pennsylvania, Philadelphia, USA. jdraine@sp2.upenn.edu

Articles citing this

Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12

Public health and the epidemic of incarceration. Annu Rev Public Health (2012) 1.85

The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model. PLoS One (2015) 1.46

Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39

Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35

Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33

Early identification of HIV: empirical support for jail-based screening. PLoS One (2012) 1.15

Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health (2014) 1.15

Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. AIDS Behav (2013) 1.09

HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07

Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav (2013) 1.07

HIV Treatment in the Criminal Justice System: Critical Knowledge and Intervention Gaps. AIDS Res Treat (2011) 1.06

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav (2013) 1.02

Efficacy of a group-based multimedia HIV prevention intervention for drug-involved women under community supervision: project WORTH. PLoS One (2014) 0.97

Partner violence and health among HIV-infected jail detainees. Int J Prison Health (2013) 0.88

Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention. Curr HIV/AIDS Rep (2014) 0.87

The role of jails in engaging PLWHA in care: from jail to community. AIDS Behav (2013) 0.87

Health outcomes for HIV-infected persons released from the New York City jail system with a transitional care-coordination plan. Am J Public Health (2015) 0.85

Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index. Acad Emerg Med (2013) 0.84

Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention. AIDS Behav (2013) 0.81

Validation of a Brief Measure of Opioid Dependence: The Rapid Opioid Dependence Screen (RODS). J Correct Health Care (2015) 0.79

Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study. J Correct Health Care (2015) 0.79

HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. AIDS Care (2015) 0.77

Women in community corrections in New York City: HIV infection and risks. Int J STD AIDS (2016) 0.75

Transitional care for formerly incarcerated persons with HIV: protocol for a realist review. Syst Rev (2017) 0.75

Emergency department use among HIV-infected released jail detainees. J Urban Health (2015) 0.75

Childhood Adversities and Substance Misuse Among the Incarcerated: Implications for Treatment and Practice in Correctional Settings. Subst Use Misuse (2017) 0.75

Articles by these authors

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04

Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis (2004) 6.27

Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med (2003) 4.30

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20

Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med (2014) 3.96

A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58

Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54

Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J Urban Health (2009) 3.00

Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis (2010) 2.62

A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38

Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff (Millwood) (2014) 2.21

Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12

Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Womens Health (Larchmt) (2011) 2.10

Male Incarceration Rates and Rates of Sexually Transmitted Infections: Results From a Longitudinal Analysis in a Southeastern US City. Sex Transm Dis (2015) 1.99

Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86

Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved (2008) 1.81

Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep (2005) 1.76

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73

Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med (2002) 1.66

Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health (2010) 1.66

Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65

Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis (2012) 1.61

Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend (2008) 1.60

Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis (2006) 1.55

Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS (2011) 1.52

US experience of smoke-free prisons. BMJ (2005) 1.51

Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50

Development and implementation of the cross-site evaluation of the CDC/HRSA corrections demonstration project. AIDS Educ Prev (2002) 1.50

Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend (2007) 1.50

Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav (2011) 1.49

iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment. Transplantation (2016) 1.49

HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48

Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47

Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read (2008) 1.42

HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications. Int J Drug Policy (2007) 1.40

Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39

Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39

Exploring the "bisexual bridge": a qualitative study of risk behavior and disclosure of same-sex behavior among black bisexual men. Am J Public Health (2010) 1.38

A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37

Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One (2012) 1.37

Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr (2006) 1.33

Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One (2009) 1.33

Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33

Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ (2013) 1.33

A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One (2009) 1.32

HIV control efforts should directly address incarceration. Lancet Infect Dis (2007) 1.31

Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis (2007) 1.31

Clinical care of the HIV-infected drug user. Infect Dis Clin North Am (2007) 1.30

Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav (2010) 1.29

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2009) 1.29

Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations. Clin Infect Dis (2008) 1.26

Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26

HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25

Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24

Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. J Acquir Immune Defic Syndr (2007) 1.24

The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23

The impact of needle exchange-based health services on emergency department use. J Gen Intern Med (2002) 1.22

Partners and processes in HIV services for inmates and ex-offenders. Facilitating collaboration and service delivery. Eval Rev (2003) 1.22

Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care STDS (2009) 1.22

Tobacco use among Native Hawaiian middle school students: its prevalence, correlates and implications. Ethn Health (2007) 1.22

Rapid HIV testing in rapidly released detainees: next steps. Sex Transm Dis (2009) 1.17

Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend (2013) 1.15

Early identification of HIV: empirical support for jail-based screening. PLoS One (2012) 1.15

Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health (2014) 1.15

Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis (2015) 1.13

Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend (2009) 1.12

Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS (2010) 1.11

Emergency department use by released prisoners with HIV: an observational longitudinal study. PLoS One (2012) 1.11

Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav (2007) 1.11

Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav (2013) 1.11

Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr (2011) 1.10

Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. AIDS Behav (2013) 1.09

Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr (2011) 1.09

Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics. J Acquir Immune Defic Syndr (2011) 1.09

Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend (2011) 1.09

The association between history of violence and HIV risk: a cross-sectional study of HIV-negative incarcerated women in Connecticut. Womens Health Issues (2007) 1.08

Acceptance of HIV testing among African-American college students at a historically black university in the south. J Natl Med Assoc (2006) 1.08

HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07

Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav (2013) 1.07

MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol (2013) 1.06

Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Subst Abus (2011) 1.06

A review of the case for hepatitis B vaccination of high-risk adults. Am J Med (2003) 1.06

Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend (2005) 1.06

The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One (2013) 1.06

Jails, HIV testing, and linkage to care services: an overview of the EnhanceLink initiative. AIDS Behav (2013) 1.05

Sp1 transcription factor as a molecular target for nitric oxide-- and cyclic nucleotide--mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells. Circ Res (2002) 1.05